anonymous
Guest
anonymous
Guest
What impact can this have on Novo staying afloat and what insight can the field provide on if/how they will be pushing this?
Is it too little too late or can this provide some respite to concerns for our Q2 financial assessment?
Is it too little too late or can this provide some respite to concerns for our Q2 financial assessment?